Coherus BioSciences to Present at Bank of America Merrill Lynch Health Care Conference on May 11 Biotech Investing
Cancer Genetics, Inc. Significantly Expands Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Trials In Progress With Leading Biotech and Pharma Companies Biotech Investing
Gelesis Announces Positive Safety Data from First-In-Human Study of Second Product Candidate, Gelesis200 Biotech Investing
Trevena Announces Successful End-of-Phase 2 Meeting with FDA and Outlines Phase 3 Program for Oliceridine Biotech Investing
Stemline Therapeutics Clears First Cohort of Patients in Ongoing SL-801 Phase 1 Trial Biotech Investing
Apricus Biosciences to Host Live Webcast KOL Event on May 9th Addressing Vitaros® and Erectile Dysfunction Population Biotech Investing
Naturally Splendid: A Leader in the Science of Hemp and Omega-based Product Development Biotech Investing
Ignyta Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares Biotech Investing
Oligomerix Awarded a Grant for its Alzheimer’s Drug Discovery Program Targeting Tau Oligomers from the National Institutes of Health Biotech Investing
